Chronic Refractory Cough Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Chronic Refractory Cough Market is segmented By Treatment (Antitussives, Expectorants, Combination Medications), By Route of Administration (Oral, Inhalation, Injectable), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Chronic Refractory Cough Market Size
Market Size in USD
CAGR8.2%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 8.2% |
| Market Concentration | Medium |
| Major Players | Merck & Co., Inc., Bellus Health Inc., Bayer AG, AstraZeneca plc, GlaxoSmithKline plc |
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
Want to purchase customized report?
please let us know !
please let us know !
Chronic Refractory Cough Market Analysis
The chronic refractory cough market is estimated to be valued at USD 1.62 Bn in 2024 and is expected to reach USD 2.82 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031. The increasing prevalence of chronic respiratory diseases and growing demand for non-codeine medications are major factors contributing to the growth of this market.